Search

Your search keyword '"Francesco, Russo"' showing total 62 results

Search Constraints

Start Over You searched for: Author "Francesco, Russo" Remove constraint Author: "Francesco, Russo" Journal digestive and liver disease Remove constraint Journal: digestive and liver disease
62 results on '"Francesco, Russo"'

Search Results

1. Increased platelet aggregation in patients with cirrhosis and hepatocellular carcinoma: A new potential therapeutic target?

2. Pregnancy after liver transplantation: a survey from Italian liver transplants centres

3. OC.04.8 IMPACT OF COVID-19 PANDEMIC ON REFERRAL OF PATIENTS WITH LIVER DISEASE TO A LIVER TRANSPLANT CENTER

4. AF.23 HELICOBACTER PYLORI PRIMARY AND SECONDARY GENOTYPIC RESISTANCE TO CLARITHROMYCIN AND LEVOFLOXACIN DETECTION IN STOOLS: A 4-YEAR SCENARIO IN SOUTHERN ITALY

5. AF.25 FALSE NEGATIVITY OF RAPID UREASE TEST FOR HELICOBACTER PYLORI DIAGNOSIS: COMPARISON WITH OTHER DIAGNOSTIC TESTS

6. Role of cellular senescence in the natural history of primary sclerosing cholangitis

8. Role of a dedicated referral system for patients with liver disease and potential indication for liver transplantation: prospective data from a single centre experience

9. OC.05.3 ENDOTHELIAL DAMAGE IN THE PORTAL VEIN OF PATIENTS WITH CIRRHOSIS

10. T06.01.4 IMPACT OF PRE-TRANSPLANT SARCOPENIA ON SHORT TO MEDIUM TERM OUTCOME IN LIVER TRANSPLANT RECIPIENTS WITH AND WITHOUT HEPATOCELLULAR CARCINOMA

11. PC.01.5 INFECTIONS IN CIRRHOSIS: A CHANGING EPIDEMIOLOGIC SETTING

13. The weight of pre-existing cofactors for liver disease progression in patients who successfully eradicated HCV virus infection: An interim analysis in the PITER cohort

14. Infection in cirrhosis: a changing epidemiologic setting

15. Long-term liver fibrosis and outcomes in HCV-infected solid organ transplant recipients after DAAs-induced viral eradication

16. OC.01.2 DE NOVO NEOPLASMS AFTER LIVER TRANSPLANTATION: DONOR GENDER AND AGE INFLUENCE

17. Treatment of 320 genotype 3 cirrhotic patients with 12 weeks Sofosbuvir/Velpatasvir with or without ribavirin: real life experience from Italy

18. Efficacy and safety of Elbasvir/Grazoprevir in a large real-life cohort of HCV-infected patients

19. Portal endothelial damage in cirrhosis

20. P.09.5 ASSESSING THE RISK OF DE NOVO NEOPLASMS AFTER LIVER TRANSPLANTATION: ROLE OF HEPATOCELLULAR CARCINOMA

22. Pathological characteristics and early post-hepatic-resection outcome of patients with hepatocellular carcinoma occurred after hepatitis C treatment with new direct-acting antivirals: A multicenter cohort study

23. Forecasting liver disease burden

25. P.04.7 PREVALENCE OF DE NOVO METABOLIC SYNDROME AND ITS RISK FACTORS IN A LIVER TRANSPLANTED POPULATION: A PROSPECTIVE STUDY

26. P.04.13 THE ROLE OF IMMUNE PROFILE IN PATIENTS WITH SEVERE ALCOHOLIC HEPATITIS IN PREDICTING MORTALITY AND THE DEVELOPMENT OF INFECTIONS: A PROSPECTIVE EVALUATION

28. P.04.17 IMPACT OF DAA IN PATIENTS WHO UNDERGOING SOLID ORGAN TRANSPLANTATION

29. The role of delta creatinine and serum albumin in predicting mortality in patients with severe alcoholic hepatitis and infection

30. Magnetic resonance risk score and liver stiffness by transient elastography have complementary prognostic values in patients with Primary Sclerosing Cholangitis

31. Effectiveness and safety of Sofosbuvir/Velpatasvir/Voxilaprevir for retreatment of chronic hepatitis C patients with a previous failure to direct-acting antivirals: a real-life study from the Navigatore Lombardia and Veneto Networks

32. The role of alcoholic liver disease as risk factor for the development of de novo metabolic syndrome after liver transplantation: a prospective longitudinal study

33. Long-term liver function changes and related risk factors after direct-acting antiviral therapy in HCV-infected cirrhotic patients: results from a prospective web-based regional platform

34. Outcome of critically ill patients with cirrhosis and ACLF after ICU admission

35. Early liver transplantation for severe acute alcoholic hepatitis: Pilot program in a single transplant centre in Italy

37. Assessing the risk of de novo neoplasms after liver transplantation: Role of pre-transplant hepatocellular carcinoma

39. Presentation and outcome in patients with drug induced liver injury: A three-year experience

40. OC.03.9 SPONTANEOUS BACTERIAL PERITONITIS (SBP) IS NOT ASSOCIATED WITH HIGHER MORTALITY IF COMPARED WITH OTHER INFECTIONS IN PATIENTS AWAITING LIVER TRANSPLANTATION (LT)

41. F-48 Liver transplantation for HBV-related liver disease: the experience of Padua Liver Transplant Center

42. T-52 The role of immunity and gender during acute liver injury

43. OC-5 Systemic administration of a novel human umbilical cord mesenchymal stem cells population accelerates the resolution of acute liver injury

44. F-25 Prospective validation of noninvasive methods to assess liver fibrosis in HCV patients after liver transplantation (LT)

45. P.16.10 EFFECTS OF NON SELECTIVE β-BLOCKERS (NSBB) ON HEMODYNAMICS AND PARACENTESIS INDUCED CIRCULATORY DYSFUNCTION IN CIRRHOTIC PATIENTS UNDERGOING LARGE VOLUME PARACENTESIS (LVP)

46. Effects of Non-Selective β-Blockers on hemodynamic and Paracentesis Induced Circulatory Dysfunction in cirrhotics undergoing large volume paracentesis

47. P.161 SELF-REPORTED ADHERENCE TO MEDICAL REGIMEN BEFORE AND AFTER LIVER TRANSPLANTATION (LT)

48. Histological HCV recurrence after liver transplantation (LT): The impact of antiviral therapy on fibrosis progression

50. P.1.82: ADEQUATE POLYPECTOMY FOR SMALL AND DIMINUTIVE COLORECTAL POLYPS: COLD SNARE VERSUS COLD BIOPSY FORCEPS

Catalog

Books, media, physical & digital resources